YOUR DOCTOR RECOMMENDED PRODUCT
Trust the experts: We partner with your medical provider to offer home delivery for the products they recommend.
Product Description: nūmaqula omega-3 provides early macular support for the macula, the vision-critical tissue in the back of the eye. Studies show that daily intake of omega-3s (EPA and DHA), Lutein and Zeaxanthin help to protect the health of the macula before any signs of decline are visible.
Servings per bottle: 90 servings = 90 days (3 months). Ordering options below are for 1 bottle (3 month supply), 2 bottles (6 month supply), or 4 bottles (12 month supply).
PRODUCT FAQs
Q: How does nūmaqula omega-3 compare to store-bought fish oil?
A: nūmaqula omega-3 contains 1840mg of EPA and DHA in an ultra-purified triglyceride (rTG) form, which is a similar form to a piece of fish, but without the impurities. This form is easier for your body to absorb and micro-distilled to remove contaminants like PCBs, lead, mercury and more. Many store-bought omega-3s contain less than 600mg of EPA and DHA and are in a synthetic (ester) or unpurified form, which is difficult to absorb and leaves a fishy odor/aftertaste.
Q: Can I get a sufficient amount of Omega-3s from just eating fish?
A: The American Heart Association and the American Cardiology Association recommend 2-3 grams of omega-3s daily (EPA+DHA). To get this amount of Omega 3s (generally equal to 3 soft gels of PRN Omega 3s daily) from eating fish, you would have to consume the equivalent of 37 cans of tuna per week! Eating this much fish could result in an increased risk for mercury poisoning. Other fish that can be purchased in stores are mostly farm-raised which have little Omega-3s, or wild-caught, which are optimal but have an increased risk of being contaminated with harmful PCBs, dioxins, mercury, etc.
Q: Why not Flaxseed oil?
A: Flaxseed contains the plant source of Omega-3s, also known as alpha-linolenic acid (ALA). This form is less easy to absorb and less effective in the body. Marine-based Omega-3s have been shown to be more absorbable which may provide systemic benefits.*
- JAMA. 2013; 309(19):2005-2015 Lutein +Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
- Sangiovanni, J. P., Agrón, E., Meleth, A. D., Reed, G. F., Sperduto, R. D., Clemons, T. E., Chew, E. Y., & Age-Related Eye Disease Study Research Group (2009). {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. The American journal of clinical nutrition, 90(6), 1601–1607. https://doi.org/10.3945/ajcn.2009.27594
* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Not eligible for retail discounts or any type of promotion.
